Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2002 May;39(5):311–314. doi: 10.1136/jmg.39.5.311

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

D Evans 1, M Baser 1, J McGaughran 1, S Sharif 1, E Howard 1, A Moran 1
PMCID: PMC1735122  PMID: 12011145

Abstract

Background: Cross sectional studies have shown that 1-2% of patients with neurofibromatosis 1 (NF1) develop malignant peripheral nerve sheath tumours (MPNST). However, no population based longitudinal studies have assessed lifetime risk.

Methods: NF1 patients with MPNST were ascertained from two sources for our north west England population of 4.1 million in the 13 year period 1984-1996: the North West Regional NF1 Register and review of notes of patients with MPNST in the North West Regional Cancer Registry.

Results: Twenty-one NF1 patients developed MPNST, equivalent to an annual incidence of 1.6 per 1000 and a lifetime risk of 8-13%. There were 37 patients with sporadic MPNST. The median age at diagnosis of MPNST in NF1 patients was 26 years, compared to 62 years in patients with sporadic MPNST (p<0.001). In Kaplan-Meier analyses, the five year survival from diagnosis was 21% for NF1 patients with MPNST, compared to 42% for sporadic cases of MPNST (p=0.09). One NF1 patient developed two separate MPNST in the radiation field of a previous optic glioma.

Conclusion: The lifetime risk of MPNST in NF1 is much higher than previously estimated and warrants careful surveillance and a low threshold for investigation.

Full Text

The Full Text of this article is available as a PDF (126.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. D'AGOSTINO A. N., SOULE E. H., MILLER R. H. PRIMARY MALIGNANT NEOPLASMS OF NERVES (MALIGNANT NEURILEMOMAS) IN PATIENTS WITHOUT MANIFESTATIONS OF MULTIPLE NEUROFIBROMATOSIS (VON RECKLINGHAUSEN'S DISEASE). Cancer. 1963 Aug;16:1003–1014. doi: 10.1002/1097-0142(196308)16:8<1003::aid-cncr2820160807>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  2. Das Gupta T. K., Brasfield R. D. Solitary malignant schwannoma. Ann Surg. 1970 Mar;171(3):419–428. doi: 10.1097/00000658-197003000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doorn P. F., Molenaar W. M., Buter J., Hoekstra H. J. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol. 1995 Feb;21(1):78–82. doi: 10.1016/s0748-7983(05)80073-3. [DOI] [PubMed] [Google Scholar]
  4. Ducatman B. S., Scheithauer B. W., Piepgras D. G., Reiman H. M., Ilstrup D. M. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986 May 15;57(10):2006–2021. doi: 10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  5. Ferner R. E., Lucas J. D., O'Doherty M. J., Hughes R. A., Smith M. A., Cronin B. F., Bingham J. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):353–357. doi: 10.1136/jnnp.68.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardner R. J., Mungall A. J., Dunham I., Barber J. C., Shield J. P., Temple I. K., Robinson D. O. Localisation of a gene for transient neonatal diabetes mellitus to an 18.72 cR3000 (approximately 5.4 Mb) interval on chromosome 6q. J Med Genet. 1999 Mar;36(3):192–196. [PMC free article] [PubMed] [Google Scholar]
  7. Ghosh B. C., Ghosh L., Huvos A. G., Fortner J. G. Malignant schwannoma. A clinicopathologic study. Cancer. 1973 Jan;31(1):184–190. doi: 10.1002/1097-0142(197301)31:1<184::aid-cncr2820310126>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  8. Greager J. A., Reichard K. W., Campana J. P., DasGupta T. K. Malignant schwannoma of the head and neck. Am J Surg. 1992 Apr;163(4):440–442. doi: 10.1016/0002-9610(92)90050-2. [DOI] [PubMed] [Google Scholar]
  9. Harris M., Hartley A. L., Blair V., Birch J. M., Banerjee S. S., Freemont A. J., McClure J., McWilliam L. J. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991 Aug;64(2):315–320. doi: 10.1038/bjc.1991.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoyt W. F., Baghdassarian S. A. Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol. 1969 Dec;53(12):793–798. doi: 10.1136/bjo.53.12.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huson S. M., Compston D. A., Clark P., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989 Nov;26(11):704–711. doi: 10.1136/jmg.26.11.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huson S. M., Compston D. A., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet. 1989 Nov;26(11):712–721. doi: 10.1136/jmg.26.11.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. King A. A., Debaun M. R., Riccardi V. M., Gutmann D. H. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet. 2000 Aug 28;93(5):388–392. [PubMed] [Google Scholar]
  14. Listernick R., Charrow J., Greenwald M. J., Esterly N. B. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989 May;114(5):788–792. doi: 10.1016/s0022-3476(89)80137-4. [DOI] [PubMed] [Google Scholar]
  15. Loree T. R., North J. H., Jr, Werness B. A., Nangia R., Mullins A. P., Hicks W. L., Jr Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors. Otolaryngol Head Neck Surg. 2000 May;122(5):667–672. doi: 10.1016/S0194-5998(00)70193-8. [DOI] [PubMed] [Google Scholar]
  16. Poyhonen M., Niemela S., Herva R. Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med. 1997 Feb;121(2):139–143. [PubMed] [Google Scholar]
  17. Sørensen S. A., Mulvihill J. J., Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986 Apr 17;314(16):1010–1015. doi: 10.1056/NEJM198604173141603. [DOI] [PubMed] [Google Scholar]
  18. Wanebo J. E., Malik J. M., VandenBerg S. R., Wanebo H. J., Driesen N., Persing J. A. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993 Feb 15;71(4):1247–1253. doi: 10.1002/1097-0142(19930215)71:4<1247::aid-cncr2820710413>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Authors' Correction]
jmedgene_39_5_311__index.html (1.1KB, html)
jmedgene_39_5_311__395311corfig.ppt (22KB, ppt)

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES